1. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
   Jose Marin et al, 2019, Cancers CrossRef
2. MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives
   Safieh Ebrahimi et al, 2019, Cellular Oncology CrossRef
3. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma
   Vrajesh Karkhanis et al, 2020, Journal of Biological Chemistry CrossRef
4. miR-509-3p enhances platinum drug sensitivity in ovarian cancer
   Leilei Niu et al, 2019, Gene CrossRef
5. ROS, Redox Regulation, and Anticancer Therapy
   Mohinder Pal Bansal, 2023, Redox Regulation and Therapeutic Approaches in Cancer CrossRef
6. The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
   Siqi Zhao et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
7. Retracted Article: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
   Shiming Yang et al, 2018, RSC Advances CrossRef
8. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma
   María Paula Ceballos et al, 2019, Current Medicinal Chemistry CrossRef
9. Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
   Ying Li et al, 2018, Oncotarget CrossRef
10. The microRNA-424/503 cluster: A master regulator of tumorigenesis and tumor progression with paradoxical roles in cancer
    Ye Wu et al, 2020, Cancer Letters CrossRef
11. Regulation of drug transporters by microRNA and implications in disease treatment
    Yoon-Jee Chae et al, 2022, Journal of Pharmaceutical Investigation CrossRef
12. MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma
    María V Espelt et al, 2019, World Journal of Hepatology CrossRef
13. Polysaccharides Produced by the Mushroom Trametes robiniophila Murr Boosts the Sensitivity of Hepatoma Cells to Oxaliplatin via the miR-224-5p/ABCB1/P-gp Axis
    Yudong Gou et al, 2022, Integrative Cancer Therapies CrossRef
14. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression
    Xuefei Zhang et al, 2020, Cell Death & Disease CrossRef
15. Non-coding RNA in drug resistance of hepatocellular carcinoma
    Bisha Ding et al, 2018, Bioscience Reports CrossRef
16. Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
    Li Lin et al, 2023, Frontiers in Oncology CrossRef
17. Liver and gastrointestinal cancers
    Jose J.G. Marin et al, 2020, Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy CrossRef
18. Emerging role of miRNAs in the regulation of ferroptosis
    Reza Mahmoudi-Lamouki et al, 2023, Frontiers in Molecular Biosciences CrossRef
19. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
    Ling Wei et al, 2019, Molecular Cancer CrossRef
20. Small GTPase RHOE/RND3, a new critical regulator of NF‐κB signalling in glioblastoma multiforme?
    Qian Sun et al, 2019, Cell Proliferation CrossRef
21. The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer
    Audrey Marjamaa et al, 2023, Scientific Reports CrossRef
22. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma
    Vrajesh Karkhanis et al, 2020, Journal of Biological Chemistry CrossRef